GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RENE.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Reneuron Group Stock and on which exchange is it traded?
The symbol for Reneuron Group is RENE.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Reneuron Group Stock?
Reneuron Group holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Reneuron Group Stock?
Reneuron Group Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Reneuron Group Stock.

What's the current price of Reneuron Group Stock?
As of the end of day on the 2024-04-17, the price of an Reneuron Group (RENE.L) share was £3.28.

What is the 52-week high and low for Reneuron Group Stock?
The 52-week high for Reneuron Group Stock is £10.80 and the 52-week low is £3.28.

What is the market capitalization of Reneuron Group Stock?
As of the 2024-04-17, the market capitalization of Reneuron Group is 1.93M.

When is the next earnings date for Reneuron Group?
The upcoming earnings date for Reneuron Group is May 23, 2024.
Click to get the best stock tips daily for free!

About Reneuron Group

Reneuron Group ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in the partnering stage in china and outside china for treating stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes... RENE.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT